247
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Clinical study of the effects on asthma-related QOL and asthma management of a medical food in adult asthma patients

, , , , &
Pages 2865-2875 | Accepted 08 Sep 2009, Published online: 08 Oct 2009

References

  • Busse WW Role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996;26:868-79
  • Busse WW Leukotrienes and inflammation. Am J Respir Critical Care Med 1998;157:S210-13
  • Peters-Golden M, Henderson WR The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 2005;94:609-18
  • Wenzel SE The role of leukotrienes in asthma. Prost Leuk Essent Fatty Acids 2003;69:145-55
  • Lands WEM, Libelt B, Morris A, et al. Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added dietary n-3 fatty acids. Biochim Biophys Acta 1992;1180:147-62
  • Vas Dias FW. Eicosanoids – a brief overview. In: (R.J. Hamilton and R.D. Rice, eds.) Fish Oil: Technology, Nutrition and Marketing. P.J. Barnes & Associates, 1995: Chap. 7, 109
  • Kapoor R, Huang Y-S. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotech 2006;7:531-4
  • Zaloga GP Dietary lipids: ancestral ligands and regulators of cell signalling pathways. Crit Care Med 1999;27:1646-8
  • Chilton-Lopez T, Surette ME, Swan DD, et al. Metabolism of gammalinolenic acid in human neutrophils. J Immunol 1996;156:2941-7
  • Chapkin RS, Miller CC, Somers SD, et al. Utilization of dihomo-gamma-linolenic acid (8,11,14-eicosatrienoic acid) by murine peritoneal macrophages. Biochim Biophys Acta 1988;959:322-31
  • Iverson L, Fogh K, Bojesen G, et al. Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds. Agents Actions 1991;33:286-91
  • Iverson L, Fogh K, Kragballe K. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res 1992;284:222-6
  • Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997;127:1435-44
  • Pullman-Mooar S, Laposata M, Lem D, et al. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990;33:1526-33
  • Ziboh VA, Fletcher MP Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. Am J Clin Nutr 1992;55:39-45
  • Mita H, Yui Y, Taniguchi N, et al. Increased activity of 5-lipoxygenase in polymorphonuclear leukocytes from asthmatic patients. Life Sci 1985;37:907-14
  • Sampson AP, Thomas RU, Costello JF, et al. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol 1992;33:423-30
  • Pacheco Y, Hosni R, Chabannes B, et al. Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest 1992; 22:732-9
  • Radeau T, Chavis C, Damon M, et al. Enhanced arachidonic acid metabolism and human neutrophil migration in asthma. Prost Leuk Essent Fatty Acids 1990;41:131-8
  • Shindo K, Koide K, Fukumura M. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax 1997;52:1024-9
  • Cheria-Sammari S, Aloui R, Gormand F, et al. Leukotriene B4 production by blood neutrophils in allergic rhinitis – effects of cetirizine. Clin Exp Allergy 1995;25:729-36
  • Barham JB, Edens MB, Fonteh AN, et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 2000;130:1925-31
  • Surette ME, Koumenis IL, Edens MB, et al. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin Ther 2003;25:948-71
  • Surette ME, Koumenis IL, Edens MB, et al. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther 2003;25:972-9
  • Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. U.S. Department of Health and Human Services. Rockville, MD: FDA/Center for Drug Evaluation and Researh, 2006. Available at www.fda.gov/CDER/GUIDANCE/5460dft.pdf [Last accessed 28 February 2008]
  • Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83
  • Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999;115:1265-70
  • Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999;14:32-8
  • Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-7
  • Surette ME, Stull D, Lindemann J. The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life in adult asthma patients. Curr Med Res Opin 2008;24:559-67
  • National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute. NIH Publication No. 02-5074, June 2003
  • Juniper EF, O’Byrne PM, Roberts JN Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use?. Respir Med 2001;95:319-23
  • Juniper EF Assessing asthma control. Curr Allergy Asthma Rep 2007;7:390-4
  • Juniper EF, Bousquet J, Abetz L, et al. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006;100:616-21
  • Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 1960;235:2595-9
  • Assay details. Available at: http://www.caymanchem.com/pdfs/520411.pdf [Last accessed 28 September 2009]
  • Moy ML, Israel E, Weiss ST, et al. Clinical predictors of health-related quality of life depend on asthma severity. Am J Resp Crit Care Med 2001;163:924-9
  • Juniper EF, Price DB, Stampone PA, et al. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002;121:1824-32
  • Pinnock H, Juniper EF, Sheikh A. Concordance between supervised and postal administration of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ) was very high. J Clin Epidemiol 2005;58:809-14
  • Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomized trials. BMJ 1998;316:690-3
  • Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7
  • Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007;178:496-502
  • Hederos C-A, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494-7
  • Ebden P, Bevan C, Banks A, et al. A study of evening primrose seed oil in atopic asthma. Prost Leuk Essent Fatty Acids 1989;35:69-72
  • Stenius-Aarniala B, Aro A, Hakulinen A, et al. Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 1989;62:534-7
  • Ziboh VA, Naguwa S, Vang K, et al. Suppression of Leukotriene B4 generation by ex vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol 2004;11:13-21
  • Kirsch CM, Payan DG, Wong MYS, et al. Effect of eicosapentaenoic acid in asthma. Clin Allergy 1988;18:177-87
  • McDonald CF, Vecchio L, Pierce RJ, et al. Effect of fish-oil derived omega-3 fatty acid supplements on asthma control (Abstract). Aust NZ J Med 1990;20:526
  • Picado C, Castillo JA, Schinca N, et al. Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. Thorax 1988;43:93-7
  • Broughton KS, Johnson CS, Pace BK, et al. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotrienes production. Am J Clin Nutr 1997;65:1011-17
  • Hodge L, Salome CM, Hughes JM, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998;11:361-5
  • Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991;95:156-7
  • Thien FCK, Mencia-Huerta J-M, Lee TH Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis 1993;14:1138-43
  • Mickleborough TD, Murray RL, Ionescu AA, et al. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003;168:1181-9
  • Mickleborough TD, Lindley MR, Ionescu AA, et al. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006;129:39-49
  • Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in ω-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000;16:861-5
  • Arm JP, Horton CE, Spur BW, et al. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989;139:1395-400
  • Arm JP, Horton CE, Mencia-Huerta J-M, et al. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988;43:84-92
  • Guichardant M, Trailter H, Spielmann D, et al. Stearidonic acid, an inhibitor of the 5-lipoxygenase pathway. A comparison with timnodonic and dihomogammalinolenic acid. Lipids 1993;28:321-4
  • Schubert R, Kitz R, Beermann C, et al. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults. Nutrition 2007;23:724-30
  • FDA. Substances affirmed as generally recognized as safe: Menhaden oil; Final rule (21 CFR, Part 184, Docket No. 86G-0289). Federal Register 1997;62:30751-7
  • FDA. Agency Response Letter 2004; GRAS Notice No. GRN 000138 [Fish Oil]. U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Food Additive Safety; College Park, MD. Available at http://www.cfsan.fda.gov/~rdb/opa-g138.html [Last accessed 28 February 2008]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.